Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Phase 3
Completed
- Conditions
- Idiopathic Hypersomnia
- Interventions
- First Posted Date
- 2021-12-14
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Harmony Biosciences, LLC
- Target Recruit Count
- 214
- Registration Number
- NCT05156047
- Locations
- 🇺🇸
Phoenix Medical Group, Peoria, Arizona, United States
🇺🇸Mayo Clinic, Scottsdale, Arizona, United States
🇺🇸Cedars-Sinai Medical Towers, Los Angeles, California, United States
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
- Conditions
- Narcolepsy Without CataplexyNarcolepsy With Cataplexy
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Harmony Biosciences, LLC
- Registration Number
- NCT03433131
- Locations
- 🇺🇸
Sleep Disorders Center of Alabama, Birmingham, Alabama, United States
🇺🇸CPC, Cullman, Alabama, United States
🇺🇸Xenoscience, Phoenix, Arizona, United States
News
No news found